This content is machine translated Lipid management: LDL cholesterol reduction Add-on to statin therapy recommended in patients at high cardiovascular risk Numerous empirical studies confirm that there is a causal relationship between high LDL cholesterol levels and cardiac events. The current motto with regard to LDL cholesterol reduction is “the lower,…
View Post 12 min This content is machine translated Subsegmental pulmonary emboli In need of therapy or clinically irrelevant? Pulmonary embolism (LE) is grouped together with deep vein thrombosis as venous thromboembolism. Whereas 50 years ago the diagnosis was usually made post-mortem or in the presence of definite clinical… CME-Test
View Post 4 min This content is machine translated Lipid lowering: "The lower, the better" is possible High-risk patients achieve ESC/EAS LDL-C targets in everyday practice. The European observational study HEYMANS with almost 2000 patients has proven that patients with very high cardiovascular risk reach the new target values European Society of Cardiology (ESC) with appropriate…
View Post 3 min This content is machine translated High-risk cardiovascular patients. Strong reduction of LDL-C levels in daily practice achievable by combination therapies Current treatment guidelines recommend low low-density lipoprotein cholesterol (LDL-C) levels for high-risk cardiovascular patients, which are unlikely to be achieved by statin therapy alone [1,2]. The fact that cardiovascular high-risk…
View Post 2 min This content is machine translated Lipid Management Guideline-compliant care up to date A fundamental factor in the field of cardiology is LDL cholesterol. Because without cholesterol, there is no atherosclerosis. Therefore, effective lipid management is paramount for the prevention of cardiovascular events.…
View Post 3 min This content is machine translated SGLT2 inhibitors Cardioprotective effect proven and found to be good – a statement One of the serious long-term consequences of diabetes mellitus is cardiovascular disease. Heart failure, in particular, is common in patients who have had diabetes for a long time. Recent study…
View Post 3 min This content is machine translated Angina pectoris Antianginal therapy shows no long-term benefit for prophylaxis Angina may persist or recur despite successful revascularization with percutaneous coronary intervention. In these cases, antianginal treatment is supplemented. To demonstrate the effectiveness of this approach, a clinical trial was…
View Post 12 min This content is machine translated Venous thromboembolism Risks associated with hormone therapy Venous thromboembolism (VTE) is the third most common cardiovascular disease in Central Europe. They manifest as deep vein thrombosis in about two-thirds of cases and with symptoms of pulmonary embolism… CME-Test
View Post 2 min This content is machine translated Anticoagulant therapy in COVID-19 patients. Antibodies to platelets promote thrombosis in COVID-19 infections. Early in the coronavirus pandemic, increased activation of blood clotting was noted in patients with COVID-19 infection. Coagulation studies at the University Hospital of Tübingen now show that platelets from…
View Post 2 min This content is machine translated Atrial fibrillation Mobile rhythm patch can detect atrial fibrillation at an early stage A mobile rhythm patch detects atrial fibrillation in high-risk patients ten times more frequently than conventional diagnostics. That is the finding of a new transatlantic study involving researchers from Canada…
View Post 4 min This content is machine translated Increased risk of dementia A weak heart is bad for the brain Heart problems result in impaired gene activity in the memory center of the brain, from which cognitive decline develops. Researchers at the German Center for Neurodegenerative Diseases (DZNE), the University…
